Comparative guide · 7 min read

Acetyl-L-carnitine vs phosphatidylserine for cognition

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships

Both supplements have decades of trials in age-associated cognitive complaints, both have plausible mechanisms, and both sit at Tier 2 in our database. The right one depends on the dominant complaint. ALCAR has its strongest evidence in chemo-fog, diabetic neuropathy, and male fertility, with a smaller but meaningful cognitive signal in older adults. Phosphatidylserine has its strongest evidence in age-associated memory complaints and ADHD-like attention deficits in non-ADHD adults.

Quick verdict

GoalBetter choiceWhy
Age-associated memory complaints (50+)PhosphatidylserineCrook 1991 and subsequent trials show improvement in name-face recall and verbal memory at 300 mg/day for 12 weeks.
Chemotherapy-induced cognitive impairmentALCARCruciani 2009 and 2012 trials in cancer-related fatigue and chemo-cognition show benefit at 2 g/day.
Diabetic peripheral neuropathy (cognitive correlate)ALCARSima 2005 and 2007 trials show meaningful symptom and nerve-conduction improvement at 2–3 g/day.
Attention / focus complaints in non-ADHD adultsPhosphatidylserineHellhammer 2014 and 2017 trials show improvement in attention and stress reactivity at 200–400 mg/day.
Mood / mild-to-moderate depression in older adultsALCARVeronese 2018 meta-analysis suggests effect comparable to some SSRIs in older adults, although replication is modest.
Cost per effective doseALCAR (slightly)Both run $25–45/month at trial doses; ALCAR is marginally cheaper per gram of active ingredient.

How they compare on the things that matter

Mechanism — what they actually do

Acetyl-L-carnitine is the acetylated form of carnitine. It crosses the blood-brain barrier more readily than L-carnitine itself, supplies an acetyl group for acetylcholine synthesis, and supports fatty-acid oxidation in mitochondria. The cognitive theory of action is a combination of cholinergic support and improved neuronal energetics. The neuropathy effect is hypothesised to be via support of nerve-growth-factor signalling and improved axonal transport.

Phosphatidylserine is a phospholipid concentrated in neuronal membranes. Supplementation is theorised to support membrane fluidity, neurotransmitter release, and dendritic spine maintenance. Modern PS supplements are derived from soy or sunflower lecithin; the original bovine-cortex PS used in early trials is no longer available (BSE concerns). Soy-derived PS has the bulk of modern human trial data.

Evidence base

Safety and side-effects

ALCAR is well tolerated at 1.5–3 g/day. Common side effects are mild — restlessness, GI upset, occasional fishy body odour at higher doses (from trimethylamine). Theoretical interaction with thyroid hormone (mild antagonism in older trials) is rarely clinically meaningful but worth noting in hypothyroid patients. Avoid in seizure disorders (rare reports of lowered seizure threshold). Use cautiously with anticoagulants.

Phosphatidylserine is well tolerated at 100–400 mg/day. GI upset is the most common complaint. Mild antiplatelet/anticoagulant effect — pause 1–2 weeks before surgery and use cautiously with warfarin or DOACs. Soy-derived PS is acceptable for most soy-allergic patients (the protein is removed) but worth verifying with allergist input if allergy is severe.

Practical rule. If the dominant complaint is age-associated memory or attention slipping, phosphatidylserine has the cleaner literature. If the dominant complaint includes neuropathic symptoms, cancer-treatment-related cognition, or mood-with-fatigue, ALCAR is the better-evidenced pick. They can be used together at moderate doses if you want both effects.

What the price difference buys you

ALCAR runs $20–35/month at 1500 mg/day. Phosphatidylserine (soy-derived, 300 mg/day) runs $25–40/month. Sharp-PS branded sunflower-derived PS is more expensive ($40–60/month). Per dollar of evidence, both are similar; choose by indication, not price.

Who should skip each

ALCAR should be avoided or approached cautiously in patients with seizure disorders, hypothyroidism (until thyroid function is stable), and active mania (rare reports of agitation in bipolar patients). Pregnancy use is not well established — defer to clinician.

Phosphatidylserine should be paused 1–2 weeks before surgery and used cautiously with warfarin or DOACs. Patients on cholinesterase inhibitors (donepezil, rivastigmine) should discuss with their neurologist — combined cholinergic load is rarely problematic but worth flagging. Pregnancy use is not well established.

What we'd actually buy

For age-associated memory complaints in someone 50+ or for attention-focus complaints in a non-ADHD adult: phosphatidylserine 300 mg/day (Sharp-PS or comparable soy-derived) for a 12-week trial. Combine with the rest of the evidence-based cognition foundation (omega-3, vitamin D, exercise, sleep).

For cancer-related fatigue, chemo-fog, or diabetic peripheral neuropathy: ALCAR 1.5–2 g/day in two divided doses for 8–12 weeks. The neuropathy trials use 3 g/day; start at 1.5 g and titrate up if tolerated. Pair with a real diabetes-care plan; ALCAR is adjunct, not substitute.

Sources

Read more: